Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2025 Earnings Call Transcript
Operator: Good morning, everyone. And welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time, all participants are in a listen-only mode.
Abeona Therapeutics Inc. (ABEO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 4,564,665 | $24,101,431 | +5% | 0.84% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 3,047,985 | $16,093,361 | -1% | 0.03% |
| 3. | Suvretta Capital Management Aaron Cowen | 2,676,000 | $14,129,280 | 0.36% | |
| 4. | Vivo Capital Albert Cha And Frank Kung | 1,842,751 | $9,729,725 | 0.78% | |
| 5. | SilverArc Capital Devesh Gandhi | 994,754 | $5,252,301 | +9% | 0.71% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.71 | 11,000 | $51,799.00 | 82,857 | 2024-05-16 | Filing | |
| $3.20 | 10,000 | $32,000.00 | 538,260 | 2024-04-25 | Filing | |
| $3.28 | 7,550 | $24,764.00 | 78,323 | 2024-04-26 | Filing | |
| $3.24 | 8,600 | $27,864.00 | 188,718 | 2024-04-25 | Filing | |
| $3.14 | 5,608 | $17,609.12 | 233,868 | 2024-04-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.74 | 15,000 | $71,167.50 | 62,252 | 2025-11-13 | Filing | |
| $5.49 | 249 | $1,365.77 | 1,189,818 | 2025-10-16 | Filing | |
| $5.39 | 9,366 | $50,515.52 | 350,763 | 2025-09-29 | Filing | |
| $5.24 | 25,000 | $130,930.00 | 1,190,067 | 2025-09-30 | Filing | |
| $5.39 | 19,274 | $103,954.32 | 1,215,067 | 2025-09-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,147,150 | $16,616,951 | 0% | |
| 2. | 2,602,901 | $13,743,318 | 0% | |
| 3. | 1,249,957 | $6,599,773 | 1.96% | |
| 4. | 1,127,131 | $5,952,529 | 0% | |
| 5. | 1,050,863 | $5,548,557 | 0.12% |
News See All
Should You Invest in Abeona Therapeutics (ABEO)?
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q2 2025 Earnings Call Transcript
Operator: Good Day everyone, and welcome to the Abeona Therapeutics Second Quarter 2025 Conference Call.
Abeona Therapeutics, AscellaHealth Partner for Commercialization of ZEVASKYN Gene Therapy
Abeona Therapeutics Inc. (NASDAQ:ABEO) is one of the stocks under $10 to buy now.
10 Stocks Under $10 to Buy Now
Earlier on July 1, Peter Kraus, Aperture Investors chairman and CEO, joined 'Squawk Box' on CNBC to suggest that the small and mid-cap area is a place for significant growth.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q1 2025 Earnings Call Transcript
Operator: Good day and welcome to the Abeona Therapeutics First Quarter 2025 Conference Call.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Abeona Therapeutics Full Year 2024 Results and Business Update Conference Call. At this time all participants are in a listen-only mode.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Abeona Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions]. Please note this conference is being recorded.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Abeona Therapeutics Second Quarter 2023 Update Conference Call [Operator Instructions]. As a reminder, today's conference is being recorded.
5 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 5 best biotech penny stocks to buy now.
Hedge Fund Resource Center Billionaire Hedge Funds
